BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31244283)

  • 1. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
    Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
    You L; Guo X; Huang Y
    Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Expression of Oct4, Nanog and CD24 Predicts Poor Response to Chemo-Radiotherapy and Unfavourable Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
    Mishra S; Tiwari V; Arora A; Gupta S; Anand N; Husain N
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2539-2547. PubMed ID: 32986350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
    Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
    Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative cancer stem cells are present in surgical margins of oral squamous cell carcinoma.
    Lazarevic M; Milosevic M; Trisic D; Toljic B; Simonovic J; Nikolic N; Mikovic N; Jelovac D; Petrovic M; Vukadinovic M; Milasin J
    J BUON; 2018; 23(6):1686-1692. PubMed ID: 30610795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced Pluripotent Stem Cell-related Genes Correlate With Poor Prognoses of Oral Squamous Cell Carcinoma.
    Muraki Y; Hasegawa T; Takeda D; Ueha T; Iwata E; Saito I; Amano R; Sakakibara A; Akashi M; Komori T
    Anticancer Res; 2019 Mar; 39(3):1205-1216. PubMed ID: 30842151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions.
    Xiao L; Song Y; Huang W; Yang S; Fu J; Feng X; Zhou M
    Reprod Biol Endocrinol; 2017 Mar; 15(1):14. PubMed ID: 28253866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa.
    Qiao B; He B; Cai J; Yang W
    Int J Clin Exp Pathol; 2014; 7(1):28-37. PubMed ID: 24427323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
    Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
    Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.
    Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM
    J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
    Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
    Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NANOG Plays a Hierarchical Role in the Transcription Network Regulating the Pluripotency and Plasticity of Adipose Tissue-Derived Stem Cells.
    Pitrone M; Pizzolanti G; Tomasello L; Coppola A; Morini L; Pantuso G; Ficarella R; Guarnotta V; Perrini S; Giorgino F; Giordano C
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells.
    Chen YL; Yen YC; Jang CW; Wang SH; Huang HT; Chen CH; Hsiao JR; Chang JY; Chen YW
    Sci Rep; 2021 Jan; 11(1):644. PubMed ID: 33436772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered immunoexpression of SOX2, OCT4 and Nanog in the normal-appearing oral mucosa of tobacco users.
    Swain N; Thakur M; Pathak J; Patel S; Hosalkar R; Ghaisas S
    Dent Med Probl; 2022; 59(3):389-395. PubMed ID: 36170598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma.
    Rodrigues MFSD; Xavier FCA; Andrade NP; Lopes C; Miguita Luiz L; Sedassari BT; Ibarra AMC; López RVM; Kliemann Schmerling C; Moyses RA; Tajara da Silva EE; Nunes FD
    Head Neck; 2018 Aug; 40(8):1759-1773. PubMed ID: 29607565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis.
    Basati G; Mohammadpour H; Emami Razavi A
    J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced Pluripotent-stem-cell Related Genes Contribute to De-differentiation in Oral Squamous Cell Carcinoma.
    Takeda D; Hasegawa T; Ueha T; Iwata E; Harada R; Sakakibara A; Kawamoto T; Minamikawa T; Sakai Y; Komori T
    Anticancer Res; 2017 Mar; 37(3):1075-1082. PubMed ID: 28314267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.